KIMS Hospitals Q1 FY27 Earnings Call Transcript Released
KIMS Hospitals reported Q1 FY'27 revenue of ₹1,196 crore, up 36.1% YoY, and EBITDA of ₹240 crore, up 20.1% YoY. PAT was ₹37 crore. The company raised ₹1,500 crore via QIP, using ₹1,100 crore for debt reduction, and ₹600 crore via preferential allotment to promoters. New units in Palakkad, Kerala opened, and Bangalore units are showing positive ramp-up.
The announcement details significant financial performance, successful fundraising of ₹2,100 crore (QIP + preferential allotment), substantial debt reduction, and positive operational updates. These factors are material and are likely to influence investor perception and the company's future growth trajectory.
The company reported strong year-on-year growth in revenue and EBITDA, alongside successful fundraising initiatives that strengthen the balance sheet. Positive commentary on new unit performance and future growth prospects contributes to a positive sentiment.
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has released the transcript of their earnings conference call with investors and analysts, held on August 04, 2026. The call, hosted by IIFL Capital Services Limited, featured key management personnel including Dr. Bhaskar Rao Bollineni (Founder & Managing Director), Dr. Abhinay Bollineni (Executive Director & CEO), and Mr. Sachin Salvi (CFO).
During the call, the management reported strong financial and operational results for Q1 FY'27. Total revenue reached ₹1,196 crore, marking a 36.1% year-on-year growth and a 10.3% quarter-on-quarter increase. EBITDA stood at ₹240 crore, up 20.1% year-on-year and 10.9% quarter-on-quarter, with an EBITDA margin of 20.1%. Profit After Tax (PAT) was ₹37 crore. Consolidated revenue from operations was ₹1,180 crore, a 35.3% year-on-year growth, and consolidated EBITDA pre-Ind AS was ₹222 crore.
Operational highlights included a 9.7% year-on-year growth in average revenue per operating bed and a 6.8% growth in average revenue per patient. Inpatient (IP) volumes grew by 26.6% year-on-year to 72,493, and outpatient (OP) volumes increased by 28.5% year-on-year to 6,58,617.
KIMS Hospitals also announced significant financial initiatives, including a Qualified Institutional Placement (QIP) that raised ₹1,500 crore, of which ₹1,100 crore was used to reduce debt. Additionally, a preferential allotment to promoters raised ₹600 crore. The company opened a new unit in Palakkad, Kerala, and provided updates on the performance of its new units in Bangalore, with Mahadevapura achieving break-even and Electronic City expected to do so in the next few quarters. The company also detailed its CAPEX strategy, focusing on stabilizing current hospitals and exploring greenfield opportunities within existing markets. The debt position as of June 30, 2026, was ₹2,570 crore, further reduced to approximately ₹2,400 crore in early July.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.